These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 8917464)

  • 1. Purification, characterization and biological evaluation of recombinant leech-derived tryptase inhibitor (rLDTI) expressed at high level in the yeast Saccharomyces cerevisiae.
    Pohlig G; Fendrich G; Knecht R; Eder B; Piechottka G; Sommerhoff CP; Heim J
    Eur J Biochem; 1996 Oct; 241(2):619-26. PubMed ID: 8917464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The three-dimensional structure of recombinant leech-derived tryptase inhibitor in complex with trypsin. Implications for the structure of human mast cell tryptase and its inhibition.
    Stubbs MT; Morenweiser R; Stürzebecher J; Bauer M; Bode W; Huber R; Piechottka GP; Matschiner G; Sommerhoff CP; Fritz H; Auerswald EA
    J Biol Chem; 1997 Aug; 272(32):19931-7. PubMed ID: 9242660
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Man alpha1-3Man alpha1-2Man and Man-linked phosphate on O-mannosylated recombinant leech-derived tryptase inhibitor produced by Saccharomyces cerevisiae and determination of the solution conformation of the mannosylated polypeptide.
    Bergwerff AA; Stark W; Fendrich G; Knecht R; Blommers MJ; Maerki W; Kragten EA; van Oostrum J
    Eur J Biochem; 1998 May; 253(3):560-75. PubMed ID: 9654051
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant leech-derived tryptase inhibitor: construction, production, protein chemical characterization and inhibition of HIV-1 replication.
    Auerswald EA; Morenweiser R; Sommerhoff CP; Piechottka GP; Eckerskorn C; Gürtler LG; Fritz H
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):695-703. PubMed ID: 7888082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of the complex of leech-derived tryptase inhibitor (LDTI) with trypsin and modeling of the LDTI-tryptase system.
    Di Marco S; Priestle JP
    Structure; 1997 Nov; 5(11):1465-74. PubMed ID: 9384562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetic and thermodynamic analysis of leech-derived tryptase inhibitor interaction with bovine tryptase and bovine trypsin.
    Erba F; Fiorucci L; Sommerhoff CP; Coletta M; Ascoli F
    Biol Chem; 2000 Nov; 381(11):1117-22. PubMed ID: 11154069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bdellastasin, a serine protease inhibitor of the antistasin family from the medical leech (Hirudo medicinalis)--primary structure, expression in yeast, and characterisation of native and recombinant inhibitor.
    Moser M; Auerswald E; Mentele R; Eckerskorn C; Fritz H; Fink E
    Eur J Biochem; 1998 Apr; 253(1):212-20. PubMed ID: 9578479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Kazal-type inhibitor of human mast cell tryptase: isolation from the medical leech Hirudo medicinalis, characterization, and sequence analysis.
    Sommerhoff CP; Söllner C; Mentele R; Piechottka GP; Auerswald EA; Fritz H
    Biol Chem Hoppe Seyler; 1994 Oct; 375(10):685-94. PubMed ID: 7888081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. C-terminal proteolytic degradation of recombinant desulfato-hirudin and its mutants in the yeast Saccharomyces cerevisiae.
    Heim J; Takabayashi K; Meyhack B; Märki W; Pohlig G
    Eur J Biochem; 1994 Dec; 226(2):341-53. PubMed ID: 8001551
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional phage display of leech-derived tryptase inhibitor (LDTI): construction of a library and selection of thrombin inhibitors.
    Tanaka AS; Silva MM; Torquato RJ; Noguti MA; Sampaio CA; Fritz H; Auerswald EA
    FEBS Lett; 1999 Sep; 458(1):11-6. PubMed ID: 10518924
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of recombinant antistasin secreted by Saccharomyces cerevisiae.
    Przysiecki CT; Joyce JG; Keller PM; Markus HZ; Carty CE; Hagopian A; Sardana MK; Dunwiddie CT; Ellis RW; Miller WJ
    Protein Expr Purif; 1992 Jun; 3(3):185-95. PubMed ID: 1392615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bis(5-amidino-2-benzimidazolyl)methane and related amidines are potent, reversible inhibitors of mast cell tryptases.
    Caughey GH; Raymond WW; Bacci E; Lombardy RJ; Tidwell RR
    J Pharmacol Exp Ther; 1993 Feb; 264(2):676-82. PubMed ID: 8437115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polycationic peptides as inhibitors of mast cell serine proteases.
    Lundequist A; Juliano MA; Juliano L; Pejler G
    Biochem Pharmacol; 2003 Apr; 65(7):1171-80. PubMed ID: 12663052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cDNA sequence of two sheep mast cell tryptases and the differential expression of tryptase and sheep mast cell proteinase-1 in lung, dermis and gastrointestinal tract.
    Pemberton AD; McAleese SM; Huntley JF; Collie DD; Scudamore CL; McEuen AR; Walls AF; Miller HR
    Clin Exp Allergy; 2000 Jun; 30(6):818-32. PubMed ID: 10848900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and evaluation of diphenyl phosphonate esters as inhibitors of the trypsin-like granzymes A and K and mast cell tryptase.
    Jackson DS; Fraser SA; Ni LM; Kam CM; Winkler U; Johnson DA; Froelich CJ; Hudig D; Powers JC
    J Med Chem; 1998 Jun; 41(13):2289-301. PubMed ID: 9632362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of phage display system and leech-derived tryptase inhibitor as a tool for understanding the serine proteinase specificities.
    Campos IT; Silva MM; Azzolini SS; Souza AF; Sampaio CA; Fritz H; Tanaka AS
    Arch Biochem Biophys; 2004 May; 425(1):87-94. PubMed ID: 15081897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone-tryptase interaction: H2A N-terminal tail removal and inhibitory activity.
    Fiorucci L; Erba F; Ascoli F
    Arch Biochem Biophys; 1997 Nov; 347(2):229-34. PubMed ID: 9367529
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mast cell tryptase from pig lungs triggers infection by pneumotropic Sendai and influenza A viruses. Purification and characterization.
    Chen Y; Shiota M; Ohuchi M; Towatari T; Tashiro J; Murakami M; Yano M; Yang B; Kido H
    Eur J Biochem; 2000 Jun; 267(11):3189-97. PubMed ID: 10824103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteinase inhibitors from the medicinal leech Hirudo medicinalis.
    Baskova IP; Zavalova LL
    Biochemistry (Mosc); 2001 Jul; 66(7):703-14. PubMed ID: 11563948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation and characterization of hirustasin, an antistasin-type serine-proteinase inhibitor from the medical leech Hirudo medicinalis.
    Söllner C; Mentele R; Eckerskorn C; Fritz H; Sommerhoff CP
    Eur J Biochem; 1994 Feb; 219(3):937-43. PubMed ID: 8112345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.